Literature DB >> 34363537

Decreased risk for substance use disorders in individuals with high-functioning autism spectrum disorder.

Amy M Yule1,2,3, Maura DiSalvo4, Joseph Biederman4,5, Timothy E Wilens4,5, Nina T Dallenbach4, Daria Taubin4, Gagan Joshi4,5.   

Abstract

The objective of this study was to evaluate the risk for developing a substance use disorder (SUD, alcohol or drug abuse or dependence) in individuals with high-functioning autism spectrum disorder (ASD). Subjects with high-functioning ASD were derived from consecutive referrals to a specialized ambulatory program for ASD at a major academic center from 2007 to 2016. Age-matched controls and attention-deficit hyperactivity disorder (ADHD) comparison subjects were derived from three independent studies of children and adults with and without ADHD using identical assessment methodology. Cox proportional hazard models were used to analyze the prevalence of SUD (alcohol or drug use disorder). Age of onset of SUD was analyzed with linear regression models. Our sample included 230 controls, 219 subjects with ADHD, and 230 subjects with ASD. The mean age for the ASD subjects was 20.0 ± 10.3 years. Among ASD subjects, 69% had a lifetime prevalence of ADHD, and the ASD subjects had significantly higher rates of other psychiatric psychopathology compared to ADHD and control subjects (p < 0.001) ASD subjects were at significantly decreased risk for developing a SUD compared to ADHD (hazard ratio (HR) = 0.22, p < 0.001) and control subjects (HR = 0.62, p = 0.04). The age of onset of a SUD was significantly older in ASD subjects, mean age 21.7 years, when compared to ADHD and control subjects (both p < 0.005). Individuals with ASD are at decreased risk to develop a SUD, and when they do, the onset is significantly later than ADHD and controls.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Autism spectrum disorder; Psychiatric comorbidity; Risk; Substance use disorder

Year:  2021        PMID: 34363537      PMCID: PMC8936975          DOI: 10.1007/s00787-021-01852-0

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  20 in total

1.  Academic and psychosocial characteristics of incoming college freshmen with autism spectrum disorder: The role of comorbidity and gender.

Authors:  Alexandra Sturm; Connie Kasari
Journal:  Autism Res       Date:  2019-04-10       Impact factor: 5.216

2.  Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS).

Authors:  P J Ambrosini
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-01       Impact factor: 8.829

3.  Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?

Authors:  Stephen V Faraone; Joseph Biederman; Thomas Spencer; Eric Mick; Kate Murray; Carter Petty; Joel J Adamson; Michael C Monuteaux
Journal:  Am J Psychiatry       Date:  2006-10       Impact factor: 18.112

4.  A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.

Authors:  J Biederman; S Faraone; S Milberger; J Guite; E Mick; L Chen; D Mennin; A Marrs; C Ouellette; P Moore; T Spencer; D Norman; T Wilens; I Kraus; J Perrin
Journal:  Arch Gen Psychiatry       Date:  1996-05

5.  Psychopathology in females with attention-deficit/hyperactivity disorder: a controlled, five-year prospective study.

Authors:  Joseph Biederman; Michael C Monuteaux; Eric Mick; Thomas Spencer; Timothy E Wilens; Kristy L Klein; Julia E Price; Stephen V Faraone
Journal:  Biol Psychiatry       Date:  2006-05-19       Impact factor: 13.382

6.  The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population.

Authors:  Gagan Joshi; Carter Petty; Janet Wozniak; Aude Henin; Ronna Fried; Maribel Galdo; Meghan Kotarski; Sarah Walls; Joseph Biederman
Journal:  J Autism Dev Disord       Date:  2010-11

7.  Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: a comparative study.

Authors:  Gagan Joshi; Janet Wozniak; Carter Petty; Mary Kate Martelon; Ronna Fried; Anela Bolfek; Amelia Kotte; Jonathan Stevens; Stephannie L Furtak; Michelle Bourgeois; Janet Caruso; Ashley Caron; Joseph Biederman
Journal:  J Autism Dev Disord       Date:  2013-06

8.  Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability.

Authors:  Bram Sizoo; Wim van den Brink; Maarten Koeter; Marielle Gorissen van Eenige; Patricia van Wijngaarden-Cremers; Rutger Jan van der Gaag
Journal:  Drug Alcohol Depend       Date:  2009-09-27       Impact factor: 4.492

9.  Risks of all-cause and suicide mortality in mental disorders: a meta-review.

Authors:  Edward Chesney; Guy M Goodwin; Seena Fazel
Journal:  World Psychiatry       Date:  2014-06       Impact factor: 49.548

10.  The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010.

Authors:  Harvey A Whiteford; Alize J Ferrari; Louisa Degenhardt; Valery Feigin; Theo Vos
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.